Relmada Therapeutics (RLMD) Gains from Investment Securities (2014)
Relmada Therapeutics' (RLMD) quarterly Gains from Investment Securities came in at $10.4 million in Q4 2014, up 113.14% on a QoQ basis from $4.9 million in Q3 2014.
Relmada Therapeutics (RLMD) Gains from Investment Securities (2014) Analysis & Trends
Relmada Therapeutics (RLMD) has 1 years of Gains from Investment Securities data on file, last reported at $10.4 million in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.62 Bn | 466.83 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Relmada Therapeutics | 449.87 Mn | 449.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 10.41 Mn |
| Dec 31, 2014 | 10.41 Mn |
| Sep 30, 2014 | 4.88 Mn |
| Sep 30, 2014 | 4.88 Mn |